Cerenome, Inc.
- CNSY
- NASDAQ
- Medical - Pharmaceuticals
- Rare Cancer Treatments
- Radiopharmaceuticals
$1.65
Today −2.94%Quote Oct 19, 2026, 04:57 PM UTC
−16.26%over the last month
Max drawdown −23.2%From 1-month high −16.3%3 months −56.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Cerenome
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Employees
28
Market value
$12.5M
Quote Oct 19
Floor
$1.63
1.4% below price
Resistance
$1.79
8.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CNSYPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free